Numab
Yannik Schmidt is currently a Research Associate at Numab Therapeutics AG, with previous experience as an Intern at Universitätsspital Basel. Yannik completed a Master of Science in Drug Sciences at the University of Basel, following a Bachelor of Science in Pharmazeutische Wissenschaften at the same university. Yannik presented their research on radiolabeling and preclinical evaluation of a new class of radiopharmaceuticals at the 34th Annual Congress of the European Association of Nuclear Medicine.
This person is not in any offices
Numab
Numab Therapeutics is an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland. At Numab, they are writing the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies.